|
Market Closed -
Nasdaq
16:00:00 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 4.900 USD | -18.27% |
|
-31.18% | -10.91% |
| 08-28 | Adial Pharmaceuticals, Inc., Azora Therapeutics, Inc. - M&A Call | |
| 08-14 | Adial Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ADIL | Delayed | |
CBOE
| ADIL | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Neutral |
| Resistance | 7.12 | 7.12 | 9.96 |
| Spread/Res. | -31.18% | -31.18% | -50.80% |
| Spread/Supp. | +23.12% | +68.38% | +255.07% |
| Support | 3.98 | 2.91 | 1.38 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ADIL Stock
- Charts Adial Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
